Skip to main content
SpringerLink
Log in

Immunity and Vaccine Development Against Helicobacter pylori

  • Chapter
  • First Online:
Helicobacter pylori in Human Diseases

Part of the book series: Advances in Experimental Medicine and Biology ((AMIDPH,volume 1149))

Abstract

Helicobacter pylori is a highly-adapted gastrointestinal pathogen of humans and the immunology of this chronic infection is extremely complex. Despite the availability of antibiotic therapy, the global incidence of H. pylori infection remains high, particularly in low to middle-income nations. Failure of therapy and the spread of antibiotic resistance among the bacteria are significant problems and provide impetus for the development of new therapies and vaccines to treat or prevent gastric ulcer, and gastric carcinoma. The expansion of knowledge on gastric conventional and regulatory T cell responses, and the role of TH17 in chronic gastritis from studies in mouse models and patients have provided valuable insights into how gastritis is initiated and maintained. The development of human challenge models for testing candidate vaccines has meant a unique opportunity to study acute infection, but the field of vaccine development has not progressed as rapidly as anticipated. One clear lesson learned from previous studies is that we need a better understanding of the immune suppressive mechanisms in vivo to be able to design vaccine strategies. There is still an urgent need to identify practical surrogate markers of protection that could be deployed in future field vaccine trials. Important developments in our understanding of the chronic inflammatory response, progress and problems arising from human studies, and an outlook for the future of clinical vaccine trials will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adamsson J, Ottsjö LS, Lundin SB, Svennerholm A-M, Raghavan S (2017) Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptoms. Cytokine 99:30–34. https://doi.org/10.1016/j.cyto.2017.06.013

    Article  CAS  PubMed  Google Scholar 

  • Aebischer T, Bumann D, Epple HJ, Metzger W, Schneider T, Cherepnev G, Walduck AK, Kunkel D, Moos V, Loddenkemper C, Jiadze I, Panasyuk M, Stolte M, Graham DY, Zeitz M, Meyer TF (2008) Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 57:1065–1072. https://doi.org/10.1136/gut.2007.145839

    Article  CAS  PubMed  Google Scholar 

  • Algood HMS, Allen SS, Washington MK, Peek RM, Miller GG, Cover TL (2009) Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol 183:5837–5846. https://doi.org/10.4049/jimmunol.0901206

    Article  CAS  PubMed  Google Scholar 

  • Ali A, Naz A, Soares SC, Bakhtiar M, Tiwari S, Hassan SS, Hanan F, Ramos R, Pereira U, Barh D, Figueiredo HCP, Ussery DW, Miyoshi A, Silva A, Azevedo V (2015) Pan-genome analysis of human gastric pathogen H. pylori: comparative genomics and pathogenomics approaches to identify regions associated with pathogenicity and prediction of potential core therapeutic targets. Biomed Res Int 2015:139580. https://doi.org/10.1155/2015/139580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anderl F, Bolz C, Busch DH, Gerhard M (2012) Therapeutic efficacy of a Helicobacter pylori vaccine dependent on antibodies and T cells. Abstract HP-83. Helsingoer, Denmark

    Google Scholar 

  • Angelakopoulos H, Hohmann EL (2000) Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68:2135–2141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Müller A (2011) Tolerance rather than immunity protects from Helicobacter pylori–induced gastric Preneoplasia. Gastroenterology 140:199–209.e8. https://doi.org/10.1053/j.gastro.2010.06.047

    Article  CAS  PubMed  Google Scholar 

  • Arnold IC, Zhang X, Urban S, Artola-Borán M, Manz MG, Ottemann KM, Müller A (2017) NLRP3 controls the development of gastrointestinal CD11b+ dendritic cells in the steady state and during chronic bacterial infection. CELREP 21:3860–3872. https://doi.org/10.1016/j.celrep.2017.12.015

    Article  CAS  Google Scholar 

  • Bagheri N, Shirzad H, Elahi S, Azadegan-Dehkordi F, Rahimian G, Shafigh M, Rashidii R, Sarafnejad A, Rafieian-Kopaei M, Faridani R, Tahmasbi K, Kheiri S, Razavi A (2017) Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection. Microb Pathog 110:165–175. https://doi.org/10.1016/j.micpath.2017.06.040

    Article  CAS  PubMed  Google Scholar 

  • Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB (1998a) Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482–492

    Article  CAS  PubMed  Google Scholar 

  • Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB (1998b) Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482–492

    Article  CAS  PubMed  Google Scholar 

  • Becher D, Deutscher ME, Simpfendorfer KR, Wijburg OL, Pederson JS, Lew AM, Strugnell RA, Walduck AK (2010) Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice. Eur J Immunol 40:2778–2790. https://doi.org/10.1002/eji.200940219

    Article  CAS  PubMed  Google Scholar 

  • Blanchard TG, Eisenberg JC, Matsumoto Y (2004) Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy. Vaccine 22:888–897. https://doi.org/10.1016/j.vaccine.2003.11.035

    Article  CAS  PubMed  Google Scholar 

  • Booth JS, Salerno-Goncalves R, Blanchard TG, Patil SA, Kader HA, Safta AM, Morningstar LM, Czinn SJ, Greenwald BD, Sztein MB (2015) Mucosal-associated invariant T cells in the human gastric mucosa and blood: role in Helicobacter pylori infection. Front Immunol 6:466. https://doi.org/10.3389/fimmu.2015.00466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bumann D, Metzger WG, Mansouri E, Palme O, Wendland M, Hurwitz R, Haas G, Aebischer T, Specht Von B-U, Meyer TF (2001) Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 20:845–852

    Article  CAS  PubMed  Google Scholar 

  • Caruso R, Fina D, Paoluzi OA, Del Vecchio Blanco G, Stolfi C, Rizzo A, Caprioli F, Sarra M, Andrei F, Fantini MC, Macdonald TT, Pallone F, Monteleone G (2008) IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 38:470–478. https://doi.org/10.1002/eji.200737635

    Article  CAS  PubMed  Google Scholar 

  • Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC, Pallone F, Macdonald TT, Monteleone G (2009) Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 136:2270–2279. https://doi.org/10.1053/j.gastro.2009.02.049

    Article  CAS  PubMed  Google Scholar 

  • Chamoun MN, Blumenthal A, Sullivan MJ, Schembri MA, Ulett GC (2018) Bacterial pathogenesis and interleukin-17: interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infection. Crit Rev Microbiol 19:1–22. https://doi.org/10.1080/1040841X.2018.1426556

    Article  Google Scholar 

  • Cherdantseva LA, Potapova OV, Sharkova TV, Belyaeva YY, Shkurupiy VA (2014) Association of Helicobacter pylori and iNOS production by macrophages and lymphocytes in the gastric mucosa in chronic gastritis. J Immunol Res 2014:762514–4. doi: https://doi.org/10.1155/2014/762514, 1

    Article  Google Scholar 

  • D’Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158:962–967

    PubMed  Google Scholar 

  • D’Souza C, Pediongco T, Wang H, Scheerlinck J-PY, Kostenko L, Esterbauer R, Stent AW, Eckle SBG, Meehan BS, Strugnell RA, Cao H, Liu L, Mak JYW, Lovrecz G, Lu L, Fairlie DP, Rossjohn J, McCluskey J, Every AL, Chen Z, Corbett AJ (2018) Mucosal-associated invariant T cells augment immunopathology and gastritis in chronic Helicobacter pylori infection. J Immunol 200:1901–1916. https://doi.org/10.4049/jimmunol.1701512

    Article  CAS  PubMed  Google Scholar 

  • Delyria ES, Redline RW, Blanchard TG (2009) Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136:247–256. https://doi.org/10.1053/j.gastro.2008.09.017

    Article  CAS  PubMed  Google Scholar 

  • Dhar P, Ng GZ, Sutton P (2016) How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer. Am J Physiol Gastrointest Liver Physiol 311:G514–G520. https://doi.org/10.1152/ajpgi.00146.2016

    Article  PubMed  Google Scholar 

  • Di Tommaso A, Xiang Z, Bugnoli M, Pileri P, Figura N, Bayeli PF, Rappuoli R, Abrignani S, De Magistris MT (1995) Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect Immun 63:1102–1106

    Article  PubMed  PubMed Central  Google Scholar 

  • DiPetrillo MD, Tibbetts T, Kleanthous H, Killeen KP, Hohmann EL (1999) Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 18:449–459

    Article  CAS  PubMed  Google Scholar 

  • Dixon MF (2001) Pathology of gastritis and peptic ulceration. In: Mobley HL, Mendz GL, Hazell SL (eds) Helicobacter pylori physiology and genetics. ASM Press, Washington, DC

    Google Scholar 

  • Eaton KA, Mefford M, Thevenot T (2001) The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 166:7456–7461

    Article  CAS  PubMed  Google Scholar 

  • Enarsson K, Lundgren A, Kindlund B, Hermansson M, Roncador G, Banham AH, Lundin BS, Quiding-Järbrink M (2006) Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin Immunol 121:358–368. https://doi.org/10.1016/j.clim.2006.07.002

    Article  CAS  PubMed  Google Scholar 

  • Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, Blaser MJ, Graham DY, Vacher S, Perez-Perez GI, Yamaoka Y, Mégraud F, Otto K, Reichard U, Katzowitsch E, Wang X, Achtman M, Suerbaum S (2003) Traces of human migrations in Helicobacter pylori populations. Science 299:1582–1585. https://doi.org/10.1126/science.1080857

    Article  CAS  PubMed  Google Scholar 

  • Flach C-FC, Mozer MM, Sundquist MM, Holmgren JJ, Raghavan SS (2012) Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice. Vaccine 30:1636–1643. https://doi.org/10.1016/j.vaccine.2011.12.111

    Article  CAS  PubMed  Google Scholar 

  • Freire de Melo F, Rocha AMC, Rocha GA, Pedroso SHSP, de Assis Batista S, Fonseca de Castro LP, Carvalho SD, Bittencourt PFS, de Oliveira CA, Corrêa-Oliveira R, Magalhães Queiroz DM (2012) A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children. Microbes Infect 14:341–347. https://doi.org/10.1016/j.micinf.2011.11.008

    Article  CAS  PubMed  Google Scholar 

  • Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556–567. https://doi.org/10.1038/nri2586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gerhard M, Schmees C, Voland P, Endres N, Sander M, Reindl W, Rad R, Oelsner M, Decker T, Mempel M, Hengst L, Prinz C (2005) A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology 128:1327–1339

    Article  CAS  PubMed  Google Scholar 

  • Graham DY, Opekun AR, Osato MS, El-Zimaity HMT, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP (2004) Challenge model for Helicobacter pylori infection in human volunteers. Gut 53:1235–1243. https://doi.org/10.1136/gut.2003.037499

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Graham DY, Lu H, Yamaoka Y (2007) A report card to grade Helicobacter pylori therapy. Helicobacter 12:275–278. https://doi.org/10.1111/j.1523-5378.2007.00518.x

    Article  PubMed  Google Scholar 

  • Guang W, Ding H, Czinn SJ, Kim KC, Blanchard TG, Lillehoj EP (2010) Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J Biol Chem 285:20547–20557. https://doi.org/10.1074/jbc.M110.121319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guang W, Twaddell WS, Lillehoj EP (2012) Molecular interactions between MUC1 epithelial mucin, β-catenin, and CagA proteins. Front Immunol 3:105. https://doi.org/10.3389/fimmu.2012.00105

    Article  PubMed  PubMed Central  Google Scholar 

  • Hall MT, Simms KT, Lew J-B, Smith MA, Saville M, Canfell K (2018) Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: example from Australia. PLoS One 13:e0185332. https://doi.org/10.1371/journal.pone.0185332

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Peña A, Rollán A, Viviani P, Guiraldes E, Schmitz JM, Lorenz RG, Novak L, Smythies LE, Smith PD (2008) Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134:491–499. https://doi.org/10.1053/j.gastro.2007.11.006

    Article  PubMed  Google Scholar 

  • Holmgren J, Nordqvist S, Blomquist M, Jeverstam F, Lebens M, Raghavan S (2018) Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: a novel and non-toxic mucosal adjuvant. Vaccine 36:1–8. https://doi.org/10.1016/j.vaccine.2018.07.073

    Article  CAS  Google Scholar 

  • Horvath DJ, Radin JN, Cho SH, Washington MK, Algood HMS (2013) The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden. PLoS One 8:e60363. https://doi.org/10.1371/journal.pone.0060363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hsu W-T, Ho S-Y, Jian T-Y, Huang H-N, Lin Y-L, Chen C-H, Lin T-H, Wu M-S, Wu C-J, Chan Y-L, Liao K-W (2018) Helicobacter pylori-derived heat shock protein 60 increases the induction of regulatory T-cells associated with persistent infection. Microb Pathog 119:152–161. https://doi.org/10.1016/j.micpath.2018.04.016

    Article  CAS  PubMed  Google Scholar 

  • Kaebisch R, Mejias-Luque R, Prinz C, Gerhard M (2013) Helicobacter pylori Cytotoxin-associated gene A impairs human dendritic cell maturation and function through IL-10-mediated activation of STAT3. J Immunol 192:316–323. https://doi.org/10.4049/jimmunol.1302476

    Article  CAS  PubMed  Google Scholar 

  • Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J (2010) Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138:1046–1054. https://doi.org/10.1053/j.gastro.2009.11.043

    Article  CAS  PubMed  Google Scholar 

  • Kaparakis MM, Laurie KLK, Wijburg OO, Pedersen JJ, Pearse MM, van Driel IRI, Gleeson PAP, Strugnell RAR (2006) CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect Immun 74:3519–3529. https://doi.org/10.1128/IAI.01314-05

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, Lechler RI, Lombardi G (2010) Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun 78:845–853. https://doi.org/10.1128/IAI.00524-09

    Article  CAS  PubMed  Google Scholar 

  • Koesling J, Lucas B, Develioglou L, Aebischer T, Meyer TF (2001) Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine 20:413–420

    Article  CAS  PubMed  Google Scholar 

  • Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC, Walker RI (2001) Safety and immunogenicity of Oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 69:3581–3590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lagunes-Servin H, Torres J, Maldonado-Bernal C, Pérez-Rodríguez M, Huerta-Yépez S, Madrazo de la Garza A, Muñoz-Pérez L, Flores-Luna L, Ramón-García G, Camorlinga-Ponce M (2013) Toll-like receptors and cytokines are upregulated during Helicobacter pylori infection in children. Helicobacter 18:423–432. https://doi.org/10.1111/hel.12067

    Article  CAS  PubMed  Google Scholar 

  • Li R, Jiang X-X, Zhang L-F, Liu X-M, Hu T-Z, Xia X-J, Li M, Xu C-X (2017) Group 2 innate lymphoid cells are involved in skewed type 2 immunity of gastric diseases induced by Helicobacter pylori infection. Mediat Inflamm 2017:4927964. https://doi.org/10.1155/2017/4927964

    Article  CAS  Google Scholar 

  • Lindholm C, Quiding-Jarbrink M, Lönroth H, Hamlet A, Svennerholm A-M (1998) Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 66:5964–5971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lundgren A, Suri-Payer E, Enarsson K, Svennerholm A-M, Lundin BS (2003) Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71:1755–1762. https://doi.org/10.1128/IAI.71.4.1755–1762.2003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lundgren A, Stromberg E, Sjöling Ã…, Lindholm C, Enarsson K, Edebo A, Johnsson E, Suri-Payer E, Larsson P, Rudin A, Svennerholm A-M, Lundin BS (2004) Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 73:523–531. https://doi.org/10.1128/IAI.73.1.523-531.2005

    Article  CAS  Google Scholar 

  • Lundgren A, Bourgeois L, Carlin N, Clements J, Gustafsson B, Hartford M, Holmgren J, Petzold M, Walker R, Svennerholm A-M (2014) Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled phase I study. Vaccine 32:7077–7084. https://doi.org/10.1016/j.vaccine.2014.10.069

    Article  CAS  PubMed  Google Scholar 

  • Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, Imeneo M, Pallone F (2000) Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 165:5332–5337

    Article  CAS  PubMed  Google Scholar 

  • Luzza F, Suraci E, Larussa T, Leone I, Imeneo M (2014) High exposure, spontaneous clearance, and low incidence of active Helicobacter pylori infection: the Sorbo San Basile study. Helicobacter 19:296–305. https://doi.org/10.1111/hel.12133

    Article  PubMed  Google Scholar 

  • Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M, Rachel Skinner S, Liu B, Cornall AM, Kaldor JM, Tabrizi SN (2018) Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination. J Infect Dis 217:1590–1600. https://doi.org/10.1093/infdis/jiy075

    Article  CAS  PubMed  Google Scholar 

  • Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SHE, Ulrichs T, Novicki D, Norelli F, Contorni M, Peppoloni S, Berti D, Tornese D, Ganju J, Palla E, Rappuoli R, Scharschmidt BF, Del Giudice G (2008) Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 135:787–795. https://doi.org/10.1053/j.gastro.2008.05.054

    Article  CAS  PubMed  Google Scholar 

  • Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM, European Helicobacter and Microbiota Study Group and Consensus panel (2017) Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report, pp 6–30

    Google Scholar 

  • Malfertheiner P, Selgrad M, Wex T, Romi B, Borgogni E, Spensieri F, Zedda L, Ruggiero P, Pancotto L, Censini S, Palla E, Kanesa-Thasan N, Scharschmidt B, Rappuoli R, Graham DY, Schiavetti F, Del Giudice G (2018) Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. Lancet Gastroenterol Hepatol 3:698–707. https://doi.org/10.1016/S2468-1253(18)30125-0

    Article  PubMed  Google Scholar 

  • Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, Weaver CT (2007) Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 8:931–941. https://doi.org/10.1038/ni1504

    Article  CAS  PubMed  Google Scholar 

  • McGuckin MA, Every AL, Skene CD, Lindén SK, Chionh Y-T, Swierczak A, McAuley J, Harbour S, Kaparakis M, Ferrero R, Sutton P (2007) Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 133:1210–1218. https://doi.org/10.1053/j.gastro.2007.07.003

    Article  CAS  PubMed  Google Scholar 

  • McGuckin MA, Lindén SK, Sutton P, Florin TH (2011) Mucin dynamics and enteric pathogens. Nat Rev Micro 9:265–278. https://doi.org/10.1038/nrmicro2538

    Article  CAS  Google Scholar 

  • Metzger WG, Mansouri E, Kronawitter M, Diescher S, Soerensen M, Hurwitz R, Bumann D, Aebischer T, Specht Von B-U, Meyer TF (2004) Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 22:2273–2277. https://doi.org/10.1016/j.vaccine.2003.11.020

    Article  CAS  PubMed  Google Scholar 

  • Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthésy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL (1999) Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116:804–812

    Article  CAS  PubMed  Google Scholar 

  • Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P (2000) Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology 119:109–118

    Article  CAS  PubMed  Google Scholar 

  • Mizuno T, Ando T, Nobata K, Tsuzuki T, Maeda O, Watanabe O, Minami M, Ina K, Kusugami K, Peek RM, Goto H (2005) Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J Gastroenterol 11:6305–6311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moodley Y, Linz B, Bond RP, Nieuwoudt M, Soodyall H, Schlebusch CM, Bernhöft S, Hale J, Suerbaum S, Mugisha L, van der Merwe SW, Achtman M (2012) Age of the association between Helicobacter pylori and man. PLoS Pathog 8:e1002693. https://doi.org/10.1371/journal.ppat.1002693

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moran AP (2007) Lipopolysaccharide in bacterial chronic infection: insights from Helicobacter pylori lipopolysaccharide and lipid A. Int J Med Microbiol 297:307–319. https://doi.org/10.1016/j.ijmm.2007.03.008

    Article  CAS  PubMed  Google Scholar 

  • Morey P, Pfannkuch L, Pang E, Boccellato F, Sigal M, Imai-Matsushima A, Dyer V, Koch M, Mollenkopf H-J, Schlaermann P, Meyer TF (2018) Helicobacter pylori depletes cholesterol in gastric glands to prevent interferon gamma signaling and escape the inflammatory response. Gastroenterology 154:1391–1404.e9. https://doi.org/10.1053/j.gastro.2017.12.008

    Article  CAS  PubMed  Google Scholar 

  • Moro K, Koyasu S (2015) Innate lymphoid cells, possible interaction with microbiota. Semin Immunopathol 37:27–37. https://doi.org/10.1007/s00281-014-0470-4

    Article  CAS  PubMed  Google Scholar 

  • Morrison PJ, Bending D, Fouser LA, Wright JF, Stockinger B, Cooke A, Kullberg MC (2013) Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation. Mucosal Immunol 6:1143–1156. https://doi.org/10.1038/mi.2013.11

    Article  CAS  PubMed  Google Scholar 

  • Mueller A, O’Rourke J, Chu P, Kim CC, Sutton P, Lee A, Falkow S (2003) Protective immunity against helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A 100:12289–12294. https://doi.org/10.1073/pnas.1635231100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Muñoz L, Camorlinga M, Hernández R, Giono S, Ramón G, Muñoz O, Torres J (2007) Immune and proliferative cellular responses to Helicobacter pylori infection in the gastric mucosa of Mexican children. Helicobacter 12:224–230. https://doi.org/10.1111/j.1523-5378.2007.00493.x

    Article  PubMed  Google Scholar 

  • Necchi V, Manca R, Ricci V, Solcia E (2009) Evidence for transepithelial dendritic cells in human H. pylori active gastritis. Helicobacter 14:208–222. https://doi.org/10.1111/j.1523-5378.2009.00679.x

    Article  CAS  PubMed  Google Scholar 

  • Nedrud JG, Czinn SJ, Ding H, Zagorski BM, Redline RW, Twaddell W, Blanchard TG (2012) Lack of genetic influence on the innate inflammatory response to helicobacter infection of the gastric mucosa. Front Immunol 3:181. https://doi.org/10.3389/fimmu.2012.00181

    Article  PubMed  PubMed Central  Google Scholar 

  • Ng GZ, Sutton P (2016) The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome. Genes Immun 17:203–206. https://doi.org/10.1038/gene.2016.10

    Article  CAS  PubMed  Google Scholar 

  • O’Ryan ML, Lucero Y, Rabello M, Mamani N, Salinas AM, Peña A, Torres-Torreti JP, Mejías A, Ramilo O, Suarez N, Reynolds HE, Orellana A, Lagomarcino AJ (2015) Persistent and transient Helicobacter pylori infections in early childhood. Clin Infect Dis 61:211–218. https://doi.org/10.1093/cid/civ256

    Article  PubMed  Google Scholar 

  • Oertli M, Noben M, Engler DB, Semper RP, Reuter S, Maxeiner J, Gerhard M, Taube C, Müller A (2013) Helicobacter pylori {gamma}-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. PNAS 110:3047–3052. https://doi.org/10.1073/pnas.1211248110

    Article  PubMed  PubMed Central  Google Scholar 

  • Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, Mohara O, Ichinose M (2004) Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 109:138–143. https://doi.org/10.1002/ijc.11680

    Article  CAS  PubMed  Google Scholar 

  • Omenetti S, Pizarro TT (2015) The Treg/Th17 Axis: a dynamic balance regulated by the gut microbiome. Front Immunol 6:639. https://doi.org/10.3389/fimmu.2015.00639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Otero LL, Ruiz VE, Perez-Perez GI (2014) Helicobacter pylori: the balance between a role as colonizer and pathogen. Best Pract Res Clin Gastroenterol 28:1017–1029. https://doi.org/10.1016/j.bpg.2014.09.003

    Article  PubMed  Google Scholar 

  • Pachathundikandi SK, Lind J, Tegtmeyer N, El-Omar EM, Backert S (2015) Interplay of the gastric pathogen Helicobacter pylori with toll-like receptors. Biomed Res Int 2015:192420. https://doi.org/10.1155/2015/192420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131. https://doi.org/10.1056/NEJM199110173251603

    Article  CAS  PubMed  Google Scholar 

  • Posselt G, Backert S, Wessler S (2013) The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal 11:77. https://doi.org/10.1186/1478-811X-11-77

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, Wagner H, Schmid RM, Prinz C (2006) CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131:525–537. https://doi.org/10.1053/j.gastro.2006.05.001

    Article  CAS  PubMed  Google Scholar 

  • Raghavan S, Quiding-Järbrink M (2016) Vaccination against Helicobacter pylori. In: Backert S, Yamaoka Y (eds) Helicobacter pylori research. Springer, Tokyo

    Google Scholar 

  • Raghavan S, Hjulström M, Holmgren J, Svennerholm A-M (2002a) Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect Immun 70:6383–6388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raghavan S, Svennerholm A-M, Holmgren J (2002b) Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect Immun 70:4621–4627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raghavan S, Fredriksson M, Svennerholm A-M, Holmgren J, Suri-Payer E (2003) Absence of CD4 +CD25 +regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 132:393–400. https://doi.org/10.1046/j.1365-2249.2003.02177.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raghavan S, Suri-Payer E, Holmgren J (2004) Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4+CD25+ regulatory T cells. Scand J Immunol 60:82–88. https://doi.org/10.1111/j.0300-9475.2004.01447.x

    Article  CAS  PubMed  Google Scholar 

  • Regev A, Fraser GM, Braun M, Maoz E, Leibovici L, Niv Y (1999) Seroprevalence of Helicobacter pylori and length of stay in a nursing home. Helicobacter 4:89–93

    Article  CAS  PubMed  Google Scholar 

  • Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2:361–367. https://doi.org/10.1038/86373

    Article  CAS  PubMed  Google Scholar 

  • Rivas-Ortiz CI, López-Vidal Y, Arredondo-Hernandez LJR, Castillo-Rojas G (2017) Genetic alterations in gastric cancer associated with Helicobacter pylori infection. Front Med 4:1–12. https://doi.org/10.3389/fmed.2017.00047

    Article  Google Scholar 

  • Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, Polson RJ, Zaitoun AM, Atherton JC (2008) Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 57:1375–1385. https://doi.org/10.1136/gut.2007.137539

    Article  CAS  PubMed  Google Scholar 

  • Rupnow MF, Shachter RD, Owens DK, Parsonnet J (2000) A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. Emerg Infect Dis 6:228–237. https://doi.org/10.3201/eid0603.000302

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rupnow MFT, Shachter RD, Owens DK, Parsonnet J (2001) Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. Vaccine 20:879–885. https://doi.org/10.1016/S0264-410X(01)00401-7

    Article  CAS  PubMed  Google Scholar 

  • Rupnow MFT, Chang AH, Shachter RD, Owens DK, Parsonnet J (2009) Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. J Infect Dis 200:1311–1317. https://doi.org/10.1086/605845

    Article  PubMed  Google Scholar 

  • Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164

    CAS  PubMed  Google Scholar 

  • Satin B, Del Giudice G, Bianca Della V, Dusi S, Laudanna C, Tonello F, Kelleher D, Rappuoli R, Montecucco C, Rossi F (2000) The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 191:1467–1476

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schenkel JM, Masopust D (2014) Tissue-resident memory T cells. Immunity 41:886–897. https://doi.org/10.1016/j.immuni.2014.12.007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schlaermann P, Toelle B, Berger H, Schmidt SC, Glanemann M, Ordemann J, Bartfeld S, Mollenkopf HJ, Meyer TF (2016) A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro. Gut 65:202–213. https://doi.org/10.1136/gutjnl-2014-307949

    Article  CAS  PubMed  Google Scholar 

  • Sigal M, Logan CY, Kapalczynska M, Mollenkopf H-J, Berger H, Wiedenmann B, Nusse R, Amieva MR, Meyer TF (2017) Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. Nature 548:451–455. https://doi.org/10.1038/nature23642

    Article  CAS  PubMed  Google Scholar 

  • Sjökvist Ottsjö L, Flach C-F, Clements J, Holmgren J, Raghavan S (2013) A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection. Infect Immun 81:1532–1540. https://doi.org/10.1128/IAI.01407-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sjökvist Ottsjö L, Flach C-F, Nilsson S, Malefyt RDW, Walduck AK, Raghavan S (2015) Defining the roles of IFN-γ and IL-17A in inflammation and protection against Helicobacter pylori infection. PLoS One 10:e0131444. https://doi.org/10.1371/journal.pone.0131444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Song Z, Zhang T, Li G, Tang Y, Luo Y, Yu G (2018) Tr1 responses are elevated in asymptomatic H. pylori-infected individuals and are functionally impaired in H. pylori-gastric cancer patients. Exp Cell Res 367:251–256. https://doi.org/10.1016/j.yexcr.2018.04.002

    Article  CAS  PubMed  Google Scholar 

  • Stenström B, Windsor HM, Fulurija A, Benghezal M, Kumarasinghe MP, Kimura K, Tay CY, Viiala CH, Ee HC, Lu W, Schoep TD, Webberley KM, Marshall BJ (2016) Helicobacter pylori overcomes natural immunity in repeated infections. Clin Case Rep 4:1026–1033. https://doi.org/10.1002/ccr3.687

    Article  PubMed  PubMed Central  Google Scholar 

  • Summerton NA, Welch RW, Bondoc L, Yang H-H, Pleune B, Ramachandran N, Harris AM, Bland D, Jackson WJ, Park S, Clements JD, Nabors GS (2010) Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin. Vaccine 28:1404–1411. https://doi.org/10.1016/j.vaccine.2009.10.147

    Article  CAS  PubMed  Google Scholar 

  • Sutton P, Boag JM (2018) Status of vaccine research and development for Helicobacter pylori. Vaccine. https://doi.org/10.1016/j.vaccine.2018.01.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sutton P, Danon SJ, Walker M, Thompson LJ, Wilson J, Kosaka T, Lee A (2001) Post-immunisation gastritis and helicobacter infection in the mouse: a long-term study. Gut 49:467–473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tanaka S, Nagashima H, Cruz M, Uchida T, Uotani T, Jiménez Abreu JA, Mahachai V, Vilaichone R-K, Ratanachu-Ek T, Tshering L, Graham DY, Yamaoka Y (2017) Interleukin-17C in human Helicobacter pylori gastritis. Infect Immun 85. https://doi.org/10.1128/IAI.00389-17

  • Tang J, Zhou X, Liu J, Meng Q, Han Y, Wang Z, Fan H, Liu Z (2015) IL-25 promotes the function of CD4+CD25+ T regulatory cells and prolongs skin-graft survival in murine models. Int Immunopharmacol 28:931–937. https://doi.org/10.1016/j.intimp.2015.03.036

    Article  CAS  PubMed  Google Scholar 

  • Velin D, Bachmann D, Bouzourene H, Michetti P (2005) Mast cells are critical mediators of vaccine-induced helicobacter clearance in the mouse model. Gastroenterology 129:142–155

    Article  CAS  PubMed  Google Scholar 

  • Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P (2009) Interleukin-17 is a critical mediator of vaccine-induced reduction of helicobacter infection in the mouse model. Gastroenterology 136:2237–2246.e1. https://doi.org/10.1053/j.gastro.2009.02.077

    Article  CAS  PubMed  Google Scholar 

  • Walduck AK, Schmitt A, Lucas B, Aebischer T, Meyer TF (2004) Transcription profiling analysis of the mechanisms of vaccine-induced protection against H. pylori. FASEB J 18:1955–1957. https://doi.org/10.1096/fj.04-2321fje

    Article  CAS  PubMed  Google Scholar 

  • Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, Derakhshan MH (2018) Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 47:868–876. https://doi.org/10.1111/apt.14561

    Article  CAS  PubMed  Google Scholar 

  • Zeng M, Mao X-H, Li J-X, Tong W-D, Wang B, Zhang Y-J, Guo G, Zhao Z-J, Li L, Wu D-L, Lu D-S, Tan Z-M, Liang H-Y, Wu C, Li D-H, Luo P, Zeng H, Zhang W-J, Zhang J-Y, Guo B-T, Zhu F-C, Zou Q-M (2015) Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386:1457–1464. https://doi.org/10.1016/S0140-6736(15)60310-5

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Science, RMIT University, Melbourne, VIC, Australia

    Anna K. Walduck

  2. Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden

    Sukanya Raghavan

Authors
  1. Anna K. Walduck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sukanya Raghavan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna K. Walduck .

Editor information

Editors and Affiliations

  1. Faculty of Health Sciences, Kyorin University, Mitaka, Tokyo, Japan

    Shigeru Kamiya

  2. Division of Microbiology; Dept of Biology, University of Erlangen-Nuremberg, Erlangen, Bayern, Germany

    Steffen Backert

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Walduck, A.K., Raghavan, S. (2019). Immunity and Vaccine Development Against Helicobacter pylori. In: Kamiya, S., Backert, S. (eds) Helicobacter pylori in Human Diseases. Advances in Experimental Medicine and Biology(), vol 1149. Springer, Cham. https://doi.org/10.1007/5584_2019_370

Download citation

Publish with us

Policies and ethics

Search

Navigation